Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes
Clinical trial NCT02265809 · COMPLETED
Trial details
- NCT number
- NCT02265809
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-03
- Primary completion
- 2016-05-26
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.